Neuropsychiatric Disease and Treatment (Mar 2015)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]

  • Wani RA,
  • Dar MA,
  • Chandel RK,
  • Rather YH,
  • Haq I,
  • Hussain A,
  • Malla AA

Journal volume & issue
Vol. 2015, no. default
pp. 863 – 864

Abstract

Read online

Wani RA, Dar MA, Chandel RK, et al Title of paper should have been “Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a randomized, open-label study”.  Read the original paper